nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—ABCB11—Dexamethasone—psoriatic arthritis	0.15	0.185	CbGbCtD
Vinblastine—ABCC1—Methotrexate—psoriatic arthritis	0.0855	0.106	CbGbCtD
Vinblastine—ABCC2—Dexamethasone—psoriatic arthritis	0.0788	0.0974	CbGbCtD
Vinblastine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0679	0.084	CbGbCtD
Vinblastine—ABCC2—Methotrexate—psoriatic arthritis	0.0633	0.0783	CbGbCtD
Vinblastine—ABCB1—Betamethasone—psoriatic arthritis	0.0442	0.0546	CbGbCtD
Vinblastine—ABCB1—Prednisolone—psoriatic arthritis	0.0436	0.0539	CbGbCtD
Vinblastine—ABCB1—Prednisone—psoriatic arthritis	0.0411	0.0509	CbGbCtD
Vinblastine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0407	0.0503	CbGbCtD
Vinblastine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0308	0.0381	CbGbCtD
Vinblastine—CYP3A4—Betamethasone—psoriatic arthritis	0.0265	0.0327	CbGbCtD
Vinblastine—CYP3A4—Prednisolone—psoriatic arthritis	0.0261	0.0323	CbGbCtD
Vinblastine—ABCB1—Dexamethasone—psoriatic arthritis	0.0257	0.0318	CbGbCtD
Vinblastine—CYP3A4—Prednisone—psoriatic arthritis	0.0247	0.0305	CbGbCtD
Vinblastine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0242	0.0299	CbGbCtD
Vinblastine—ABCB1—Methotrexate—psoriatic arthritis	0.0206	0.0255	CbGbCtD
Vinblastine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0154	0.019	CbGbCtD
Vinblastine—Pancytopenia—Auranofin—psoriatic arthritis	0.00355	0.0217	CcSEcCtD
Vinblastine—Neuropathy peripheral—Auranofin—psoriatic arthritis	0.00327	0.02	CcSEcCtD
Vinblastine—Agranulocytosis—Auranofin—psoriatic arthritis	0.00311	0.019	CcSEcCtD
Vinblastine—Peptic ulcer—Prednisolone—psoriatic arthritis	0.00284	0.0174	CcSEcCtD
Vinblastine—Alopecia—Auranofin—psoriatic arthritis	0.00265	0.0162	CcSEcCtD
Vinblastine—Peptic ulcer—Triamcinolone—psoriatic arthritis	0.00262	0.016	CcSEcCtD
Vinblastine—Peptic ulcer—Methylprednisolone—psoriatic arthritis	0.00261	0.0159	CcSEcCtD
Vinblastine—Neuritis—Prednisolone—psoriatic arthritis	0.00255	0.0156	CcSEcCtD
Vinblastine—Anaemia—Auranofin—psoriatic arthritis	0.00241	0.0147	CcSEcCtD
Vinblastine—Peptic ulcer—Betamethasone—psoriatic arthritis	0.00237	0.0145	CcSEcCtD
Vinblastine—Peptic ulcer—Dexamethasone—psoriatic arthritis	0.00237	0.0145	CcSEcCtD
Vinblastine—Neuritis—Triamcinolone—psoriatic arthritis	0.00234	0.0143	CcSEcCtD
Vinblastine—Neuritis—Methylprednisolone—psoriatic arthritis	0.00234	0.0143	CcSEcCtD
Vinblastine—Leukopenia—Auranofin—psoriatic arthritis	0.00233	0.0143	CcSEcCtD
Vinblastine—Neuritis—Betamethasone—psoriatic arthritis	0.00213	0.013	CcSEcCtD
Vinblastine—Neuritis—Dexamethasone—psoriatic arthritis	0.00213	0.013	CcSEcCtD
Vinblastine—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00208	0.0127	CcSEcCtD
Vinblastine—Peptic ulcer—Prednisone—psoriatic arthritis	0.00207	0.0126	CcSEcCtD
Vinblastine—Anorexia—Auranofin—psoriatic arthritis	0.00203	0.0124	CcSEcCtD
Vinblastine—Neuritis—Prednisone—psoriatic arthritis	0.00185	0.0113	CcSEcCtD
Vinblastine—Decreased appetite—Auranofin—psoriatic arthritis	0.00185	0.0113	CcSEcCtD
Vinblastine—Constipation—Auranofin—psoriatic arthritis	0.00182	0.0111	CcSEcCtD
Vinblastine—Extravasation—Dexamethasone—psoriatic arthritis	0.00182	0.0111	CcSEcCtD
Vinblastine—Extravasation—Betamethasone—psoriatic arthritis	0.00182	0.0111	CcSEcCtD
Vinblastine—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00174	0.0106	CcSEcCtD
Vinblastine—TUBG1—skin of body—psoriatic arthritis	0.0017	0.102	CbGeAlD
Vinblastine—Abdominal pain—Auranofin—psoriatic arthritis	0.00168	0.0103	CcSEcCtD
Vinblastine—TUBD1—tendon—psoriatic arthritis	0.00154	0.0923	CbGeAlD
Vinblastine—Diarrhoea—Auranofin—psoriatic arthritis	0.00146	0.00889	CcSEcCtD
Vinblastine—TUBE1—tendon—psoriatic arthritis	0.00145	0.0865	CbGeAlD
Vinblastine—Vomiting—Auranofin—psoriatic arthritis	0.00135	0.00826	CcSEcCtD
Vinblastine—Extravasation—Methotrexate—psoriatic arthritis	0.00132	0.00809	CcSEcCtD
Vinblastine—TUBG1—tendon—psoriatic arthritis	0.00129	0.0775	CbGeAlD
Vinblastine—Nausea—Auranofin—psoriatic arthritis	0.00126	0.00772	CcSEcCtD
Vinblastine—JUN—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.00113	0.105	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Methylprednisolone—psoriatic arthritis	0.00113	0.105	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Dexamethasone—psoriatic arthritis	0.00111	0.104	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Betamethasone—psoriatic arthritis	0.00111	0.104	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Triamcinolone—psoriatic arthritis	0.00108	0.101	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Triamcinolone—psoriatic arthritis	0.00108	0.101	CbGdCrCtD
Vinblastine—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.00105	0.00641	CcSEcCtD
Vinblastine—Neoplasm—Methotrexate—psoriatic arthritis	0.00104	0.00638	CcSEcCtD
Vinblastine—Myocardial infarction—Prednisolone—psoriatic arthritis	0.00104	0.00637	CcSEcCtD
Vinblastine—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.00104	0.00637	CcSEcCtD
Vinblastine—JUN—Dexamethasone—Prednisone—psoriatic arthritis	0.00103	0.0961	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Prednisone—psoriatic arthritis	0.00103	0.0961	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Prednisolone—psoriatic arthritis	0.001	0.0938	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Prednisolone—psoriatic arthritis	0.001	0.0938	CbGdCrCtD
Vinblastine—TUBA1A—skin of body—psoriatic arthritis	0.000984	0.0589	CbGeAlD
Vinblastine—JUN—skin of body—psoriatic arthritis	0.000975	0.0583	CbGeAlD
Vinblastine—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.000964	0.00589	CcSEcCtD
Vinblastine—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.000962	0.00588	CcSEcCtD
Vinblastine—Haemoglobin—Prednisolone—psoriatic arthritis	0.00096	0.00586	CcSEcCtD
Vinblastine—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.000959	0.00586	CcSEcCtD
Vinblastine—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.000959	0.00586	CcSEcCtD
Vinblastine—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.000957	0.00584	CcSEcCtD
Vinblastine—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.000957	0.00584	CcSEcCtD
Vinblastine—Haemorrhage—Prednisolone—psoriatic arthritis	0.000955	0.00583	CcSEcCtD
Vinblastine—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000883	0.00539	CcSEcCtD
Vinblastine—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000881	0.00538	CcSEcCtD
Vinblastine—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000878	0.00536	CcSEcCtD
Vinblastine—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000876	0.00535	CcSEcCtD
Vinblastine—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.000875	0.00535	CcSEcCtD
Vinblastine—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.000875	0.00535	CcSEcCtD
Vinblastine—Pharyngitis—Triamcinolone—psoriatic arthritis	0.000872	0.00532	CcSEcCtD
Vinblastine—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.00087	0.00531	CcSEcCtD
Vinblastine—Myocardial infarction—Betamethasone—psoriatic arthritis	0.00087	0.00531	CcSEcCtD
Vinblastine—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.00087	0.00531	CcSEcCtD
Vinblastine—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.00087	0.00531	CcSEcCtD
Vinblastine—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.000856	0.00523	CcSEcCtD
Vinblastine—TUBB4A—skin of body—psoriatic arthritis	0.000841	0.0503	CbGeAlD
Vinblastine—Haemoglobin—Betamethasone—psoriatic arthritis	0.000801	0.00489	CcSEcCtD
Vinblastine—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000801	0.00489	CcSEcCtD
Vinblastine—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000797	0.00487	CcSEcCtD
Vinblastine—Haemorrhage—Betamethasone—psoriatic arthritis	0.000797	0.00487	CcSEcCtD
Vinblastine—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000771	0.00471	CcSEcCtD
Vinblastine—Depression—Prednisone—psoriatic arthritis	0.000771	0.00471	CcSEcCtD
Vinblastine—TUBB2A—skin of body—psoriatic arthritis	0.000765	0.0458	CbGeAlD
Vinblastine—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000762	0.00465	CcSEcCtD
Vinblastine—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000758	0.00463	CcSEcCtD
Vinblastine—Myocardial infarction—Prednisone—psoriatic arthritis	0.000758	0.00463	CcSEcCtD
Vinblastine—TUBB6—skin of body—psoriatic arthritis	0.000755	0.0452	CbGeAlD
Vinblastine—Malaise—Prednisolone—psoriatic arthritis	0.00075	0.00458	CcSEcCtD
Vinblastine—TUBA1A—tendon—psoriatic arthritis	0.000749	0.0448	CbGeAlD
Vinblastine—Vertigo—Prednisolone—psoriatic arthritis	0.000747	0.00456	CcSEcCtD
Vinblastine—JUN—tendon—psoriatic arthritis	0.000742	0.0444	CbGeAlD
Vinblastine—Convulsion—Prednisolone—psoriatic arthritis	0.00072	0.0044	CcSEcCtD
Vinblastine—Hypertension—Prednisolone—psoriatic arthritis	0.000718	0.00438	CcSEcCtD
Vinblastine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000709	0.00433	CcSEcCtD
Vinblastine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000708	0.00432	CcSEcCtD
Vinblastine—Alopecia—Betamethasone—psoriatic arthritis	0.000704	0.0043	CcSEcCtD
Vinblastine—Alopecia—Dexamethasone—psoriatic arthritis	0.000704	0.0043	CcSEcCtD
Vinblastine—Discomfort—Prednisolone—psoriatic arthritis	0.000699	0.00427	CcSEcCtD
Vinblastine—Haemoglobin—Prednisone—psoriatic arthritis	0.000697	0.00426	CcSEcCtD
Vinblastine—Haemorrhage—Prednisone—psoriatic arthritis	0.000694	0.00424	CcSEcCtD
Vinblastine—Malaise—Triamcinolone—psoriatic arthritis	0.000689	0.00421	CcSEcCtD
Vinblastine—Pancytopenia—Methotrexate—psoriatic arthritis	0.000688	0.0042	CcSEcCtD
Vinblastine—Malaise—Methylprednisolone—psoriatic arthritis	0.000688	0.0042	CcSEcCtD
Vinblastine—Vertigo—Triamcinolone—psoriatic arthritis	0.000687	0.0042	CcSEcCtD
Vinblastine—Vertigo—Methylprednisolone—psoriatic arthritis	0.000685	0.00419	CcSEcCtD
Vinblastine—Convulsion—Triamcinolone—psoriatic arthritis	0.000662	0.00405	CcSEcCtD
Vinblastine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000661	0.00404	CcSEcCtD
Vinblastine—Hypertension—Triamcinolone—psoriatic arthritis	0.00066	0.00403	CcSEcCtD
Vinblastine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000659	0.00402	CcSEcCtD
Vinblastine—TUBB4B—skin of body—psoriatic arthritis	0.000656	0.0393	CbGeAlD
Vinblastine—Depression—Methotrexate—psoriatic arthritis	0.000644	0.00393	CcSEcCtD
Vinblastine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000644	0.00393	CcSEcCtD
Vinblastine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000644	0.00393	CcSEcCtD
Vinblastine—Discomfort—Triamcinolone—psoriatic arthritis	0.000643	0.00393	CcSEcCtD
Vinblastine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000642	0.00392	CcSEcCtD
Vinblastine—TUBB4A—tendon—psoriatic arthritis	0.00064	0.0383	CbGeAlD
Vinblastine—Malaise—Betamethasone—psoriatic arthritis	0.000626	0.00382	CcSEcCtD
Vinblastine—Malaise—Dexamethasone—psoriatic arthritis	0.000626	0.00382	CcSEcCtD
Vinblastine—Vertigo—Betamethasone—psoriatic arthritis	0.000623	0.00381	CcSEcCtD
Vinblastine—Vertigo—Dexamethasone—psoriatic arthritis	0.000623	0.00381	CcSEcCtD
Vinblastine—TUBB2B—tendon—psoriatic arthritis	0.000619	0.037	CbGeAlD
Vinblastine—Alopecia—Prednisone—psoriatic arthritis	0.000613	0.00375	CcSEcCtD
Vinblastine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000609	0.00372	CcSEcCtD
Vinblastine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000603	0.00368	CcSEcCtD
Vinblastine—Convulsion—Betamethasone—psoriatic arthritis	0.000601	0.00367	CcSEcCtD
Vinblastine—Convulsion—Dexamethasone—psoriatic arthritis	0.000601	0.00367	CcSEcCtD
Vinblastine—Hypertension—Dexamethasone—psoriatic arthritis	0.000599	0.00366	CcSEcCtD
Vinblastine—Hypertension—Betamethasone—psoriatic arthritis	0.000599	0.00366	CcSEcCtD
Vinblastine—TUBB—tendon—psoriatic arthritis	0.000586	0.0351	CbGeAlD
Vinblastine—Discomfort—Dexamethasone—psoriatic arthritis	0.000583	0.00356	CcSEcCtD
Vinblastine—Discomfort—Betamethasone—psoriatic arthritis	0.000583	0.00356	CcSEcCtD
Vinblastine—Haemoglobin—Methotrexate—psoriatic arthritis	0.000583	0.00356	CcSEcCtD
Vinblastine—TUBB2A—tendon—psoriatic arthritis	0.000582	0.0349	CbGeAlD
Vinblastine—Pain—Prednisolone—psoriatic arthritis	0.00058	0.00354	CcSEcCtD
Vinblastine—Haemorrhage—Methotrexate—psoriatic arthritis	0.00058	0.00354	CcSEcCtD
Vinblastine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000576	0.00352	CcSEcCtD
Vinblastine—TUBB6—tendon—psoriatic arthritis	0.000574	0.0344	CbGeAlD
Vinblastine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000561	0.00342	CcSEcCtD
Vinblastine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00056	0.00342	CcSEcCtD
Vinblastine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000559	0.00342	CcSEcCtD
Vinblastine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000559	0.00341	CcSEcCtD
Vinblastine—Anaemia—Prednisone—psoriatic arthritis	0.000558	0.00341	CcSEcCtD
Vinblastine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000554	0.00339	CcSEcCtD
Vinblastine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000554	0.00339	CcSEcCtD
Vinblastine—Malaise—Prednisone—psoriatic arthritis	0.000545	0.00333	CcSEcCtD
Vinblastine—Vertigo—Prednisone—psoriatic arthritis	0.000543	0.00332	CcSEcCtD
Vinblastine—Anorexia—Dexamethasone—psoriatic arthritis	0.00054	0.0033	CcSEcCtD
Vinblastine—Anorexia—Betamethasone—psoriatic arthritis	0.00054	0.0033	CcSEcCtD
Vinblastine—Pain—Triamcinolone—psoriatic arthritis	0.000534	0.00326	CcSEcCtD
Vinblastine—Convulsion—Prednisone—psoriatic arthritis	0.000523	0.0032	CcSEcCtD
Vinblastine—Hypertension—Prednisone—psoriatic arthritis	0.000522	0.00319	CcSEcCtD
Vinblastine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000514	0.00314	CcSEcCtD
Vinblastine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000513	0.00313	CcSEcCtD
Vinblastine—Alopecia—Methotrexate—psoriatic arthritis	0.000513	0.00313	CcSEcCtD
Vinblastine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000509	0.00311	CcSEcCtD
Vinblastine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000508	0.00311	CcSEcCtD
Vinblastine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000508	0.00311	CcSEcCtD
Vinblastine—Discomfort—Prednisone—psoriatic arthritis	0.000508	0.0031	CcSEcCtD
Vinblastine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.0005	0.00305	CcSEcCtD
Vinblastine—TUBB4B—tendon—psoriatic arthritis	0.000499	0.0299	CbGeAlD
Vinblastine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000492	0.00301	CcSEcCtD
Vinblastine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000492	0.00301	CcSEcCtD
Vinblastine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000492	0.00301	CcSEcCtD
Vinblastine—Pain—Betamethasone—psoriatic arthritis	0.000484	0.00296	CcSEcCtD
Vinblastine—Pain—Dexamethasone—psoriatic arthritis	0.000484	0.00296	CcSEcCtD
Vinblastine—Anorexia—Prednisone—psoriatic arthritis	0.00047	0.00287	CcSEcCtD
Vinblastine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000468	0.00286	CcSEcCtD
Vinblastine—Anaemia—Methotrexate—psoriatic arthritis	0.000467	0.00285	CcSEcCtD
Vinblastine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000467	0.00285	CcSEcCtD
Vinblastine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000467	0.00285	CcSEcCtD
Vinblastine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000463	0.00283	CcSEcCtD
Vinblastine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000463	0.00283	CcSEcCtD
Vinblastine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00046	0.00281	CcSEcCtD
Vinblastine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000459	0.0028	CcSEcCtD
Vinblastine—Malaise—Methotrexate—psoriatic arthritis	0.000455	0.00278	CcSEcCtD
Vinblastine—Vertigo—Methotrexate—psoriatic arthritis	0.000454	0.00277	CcSEcCtD
Vinblastine—Leukopenia—Methotrexate—psoriatic arthritis	0.000452	0.00276	CcSEcCtD
Vinblastine—Dizziness—Prednisolone—psoriatic arthritis	0.000449	0.00274	CcSEcCtD
Vinblastine—Asthenia—Triamcinolone—psoriatic arthritis	0.000448	0.00273	CcSEcCtD
Vinblastine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000448	0.00273	CcSEcCtD
Vinblastine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000448	0.00273	CcSEcCtD
Vinblastine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000447	0.00273	CcSEcCtD
Vinblastine—Paraesthesia—Prednisone—psoriatic arthritis	0.000443	0.0027	CcSEcCtD
Vinblastine—Convulsion—Methotrexate—psoriatic arthritis	0.000437	0.00267	CcSEcCtD
Vinblastine—Decreased appetite—Prednisone—psoriatic arthritis	0.000429	0.00262	CcSEcCtD
Vinblastine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000426	0.0026	CcSEcCtD
Vinblastine—Headache—Prednisolone—psoriatic arthritis	0.000425	0.0026	CcSEcCtD
Vinblastine—Discomfort—Methotrexate—psoriatic arthritis	0.000425	0.00259	CcSEcCtD
Vinblastine—Constipation—Prednisone—psoriatic arthritis	0.000422	0.00258	CcSEcCtD
Vinblastine—Dizziness—Triamcinolone—psoriatic arthritis	0.000413	0.00252	CcSEcCtD
Vinblastine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000412	0.00251	CcSEcCtD
Vinblastine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000406	0.00248	CcSEcCtD
Vinblastine—Asthenia—Betamethasone—psoriatic arthritis	0.000406	0.00248	CcSEcCtD
Vinblastine—Asthenia—Dexamethasone—psoriatic arthritis	0.000406	0.00248	CcSEcCtD
Vinblastine—ABCC2—tendon—psoriatic arthritis	0.000404	0.0242	CbGeAlD
Vinblastine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000403	0.00246	CcSEcCtD
Vinblastine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000403	0.00246	CcSEcCtD
Vinblastine—Nausea—Prednisolone—psoriatic arthritis	0.000403	0.00246	CcSEcCtD
Vinblastine—Vomiting—Triamcinolone—psoriatic arthritis	0.000397	0.00242	CcSEcCtD
Vinblastine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000396	0.00242	CcSEcCtD
Vinblastine—Anorexia—Methotrexate—psoriatic arthritis	0.000393	0.0024	CcSEcCtD
Vinblastine—Headache—Triamcinolone—psoriatic arthritis	0.000391	0.00239	CcSEcCtD
Vinblastine—Headache—Methylprednisolone—psoriatic arthritis	0.00039	0.00238	CcSEcCtD
Vinblastine—Abdominal pain—Prednisone—psoriatic arthritis	0.00039	0.00238	CcSEcCtD
Vinblastine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000387	0.00237	CcSEcCtD
Vinblastine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000387	0.00237	CcSEcCtD
Vinblastine—Dizziness—Dexamethasone—psoriatic arthritis	0.000374	0.00229	CcSEcCtD
Vinblastine—Dizziness—Betamethasone—psoriatic arthritis	0.000374	0.00229	CcSEcCtD
Vinblastine—Nausea—Triamcinolone—psoriatic arthritis	0.000371	0.00226	CcSEcCtD
Vinblastine—Paraesthesia—Methotrexate—psoriatic arthritis	0.00037	0.00226	CcSEcCtD
Vinblastine—Nausea—Methylprednisolone—psoriatic arthritis	0.00037	0.00226	CcSEcCtD
Vinblastine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000363	0.00222	CcSEcCtD
Vinblastine—Vomiting—Dexamethasone—psoriatic arthritis	0.00036	0.0022	CcSEcCtD
Vinblastine—Vomiting—Betamethasone—psoriatic arthritis	0.00036	0.0022	CcSEcCtD
Vinblastine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000358	0.00219	CcSEcCtD
Vinblastine—ABCC1—tendon—psoriatic arthritis	0.000356	0.0213	CbGeAlD
Vinblastine—Headache—Betamethasone—psoriatic arthritis	0.000355	0.00217	CcSEcCtD
Vinblastine—Headache—Dexamethasone—psoriatic arthritis	0.000355	0.00217	CcSEcCtD
Vinblastine—Asthenia—Prednisone—psoriatic arthritis	0.000354	0.00216	CcSEcCtD
Vinblastine—Pain—Methotrexate—psoriatic arthritis	0.000352	0.00215	CcSEcCtD
Vinblastine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00034	0.00207	CcSEcCtD
Vinblastine—Diarrhoea—Prednisone—psoriatic arthritis	0.000337	0.00206	CcSEcCtD
Vinblastine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000337	0.00206	CcSEcCtD
Vinblastine—Nausea—Dexamethasone—psoriatic arthritis	0.000336	0.00205	CcSEcCtD
Vinblastine—Nausea—Betamethasone—psoriatic arthritis	0.000336	0.00205	CcSEcCtD
Vinblastine—Dizziness—Prednisone—psoriatic arthritis	0.000326	0.00199	CcSEcCtD
Vinblastine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000326	0.00199	CcSEcCtD
Vinblastine—Vomiting—Prednisone—psoriatic arthritis	0.000313	0.00191	CcSEcCtD
Vinblastine—Headache—Prednisone—psoriatic arthritis	0.000309	0.00189	CcSEcCtD
Vinblastine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000304	0.00185	CcSEcCtD
Vinblastine—Asthenia—Methotrexate—psoriatic arthritis	0.000296	0.00181	CcSEcCtD
Vinblastine—Nausea—Prednisone—psoriatic arthritis	0.000293	0.00179	CcSEcCtD
Vinblastine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000282	0.00172	CcSEcCtD
Vinblastine—Dizziness—Methotrexate—psoriatic arthritis	0.000272	0.00166	CcSEcCtD
Vinblastine—Vomiting—Methotrexate—psoriatic arthritis	0.000262	0.0016	CcSEcCtD
Vinblastine—Headache—Methotrexate—psoriatic arthritis	0.000258	0.00158	CcSEcCtD
Vinblastine—Nausea—Methotrexate—psoriatic arthritis	0.000245	0.00149	CcSEcCtD
